Heres what to watch for: Increased Energy and Alertness Many patients feel less sluggish within 13 days
Muscogiuri G, DeFronzo RA, Gastaldelli A, Holst JJ
GLP-1R agonism produces: Glucose-dependent insulin secretion (insulin released only when glucose is elevated) Suppression of glucagon secretion Delayed gastric emptying (contributing to satiety) Reduced appetite via central nervous system signalling in hypothalamic nuclei Potential cardiovascular protection (observed in clinical trials of GLP-1 agonist drugs) This receptor is the foundation of the entire GLP drug class, from exenatide to semaglutide
Sacca SC, Izzotti A, Rossi P, Traverso C
Protection of Cardiovascular Tissue : Experimental research demonstrates that BPC-157 supports the integrity of endothelial cells and reduces ischemia-induced damage in cardiovascular tissues
Gave me major relief from chronic knee pain and sleep apnea